
Daewoong Pharmaceuticals Co., Ltd pursues meaningful work by collaborating with great people, working with autonomy, and choosing opportunities that create shared value for the company, customers, and society. Above all, we are committed to driving real change and innovation through what we do. Establish in 1945, Daewoong Pharmaceuticals is a leading healthcare company in Korea that has achieved consecutive successes in new drug development through constant challenge and innovation. Today, we continue to expand a diverse pipeline and next-generation platform technologies, aiming to develop first-in-class and best-in-class innovative medicines for patients worldwide. Our commitment to global standards is proven by GMP certifications from major regulatory authorities such as the U.S. FDA and EMA, along with ISO certifications that demonstrate our excellence in quality, environmental management, and occupational health and safety systems. At Daewoong, we believe that the growth of our employees fuels the growth of the company. We foster a forward-looking corporate culture by promoting smart work practices, career development, and global talent training programs. Beyond Korea, we strive to become a global healthcare leader by creating new value for healthier lives and better quality of life worldwide.
हम Daewoong Pharmaceutical के बाज़ार विस्तार को ट्रैक कर रहे हैं
पिछले 90 दिनों में 92 सिग्नल।
Daewoong Pharmaceutical का अंतरराष्ट्रीय विस्तार उसके प्रतिस्पर्धियों की तुलना में कैसा है
बार तुलना की गई कंपनियों के सापेक्ष आकार दर्शाते हैं।
कॉलम5| कंपनी | बाज़ार | नए बाज़ार | गति | गतिविधि | विस्तार स्कोर |
|---|---|---|---|---|---|
Daewoong Pharmaceuticalआप | 0 | 0 | — | 0 | 0 |
Senior Partnership & Leasing - Bali
पोस्टिंग देखेंKuta, Bali, Indonesia · 5 माह पहले
Chief Engineer - Bali
पोस्टिंग देखेंKuta, Bali, Indonesia · 5 माह पहले
Cafe Team
पोस्टिंग देखेंKuta, Bali, Indonesia · 6 माह पहले
#News 📢 대웅제약 presented integrated model-based research findings on its SGLT-2 inhibitor #Enavogliflozin, at the 2026 PAGE (PAGE - Population Approach Group Europe) conference, a leading European forum in quantitative pharmacology.This study quantitatively elucidated the causal relationship between increased urinary glucose excretion following drug administration and the reduction in glycated hemoglobin (HbA1c), and scientifically demonstrated that the absence of significant pharmacokinetic diff ...
समाप्तNot all long-acting depot platforms are created equal. The key lies in how efficiently a drug can be delivered — in a smaller volume.In Episode 2 of the "Maximizing Therapeutic Potential with CURE®" series, we explore how CURE® achieves industry-leading drug loading to deliver a once-monthly therapeutic dose with up to 4–5× less depot mass than competing platforms.#Daewoong #GLP1 #CURE #platform #obesity #diseases #longactinginjectables ...
समाप्तSmall differences in wording can easily lead to misunderstandings in pharmaceutical communication.✍️👩💻Ji Young Yoon from 대웅제약’s Medical Team took on the challenge of bringing clarity to the confusion surrounding UDCA-related scientific messages, which had been spreading across multiple channels during the pandemic. By restructuring the messaging system, she helped ensure that accurate, evidence-based information could be delivered consistently.Curious about her journey? Watch the full video no ...
सक्रियवित्तीय नेताओं ने दवा उद्योग में राष्ट्रीय विकास कोष के नवाचार संभावना का पता लगाने के लिए डेवूंग फार्मास्युटिकल के ओसोंग स्मार्ट कारखाने का दौरा किया।
डेवूंग फार्मा ने मेंटोलाइफ ब्रांड के तहत दो स्वास्थ्य पूरक लॉन्च किए: वयस्कों के लिए एंटीऑक्सीडेंट और बच्चों के लिए प्रतिरक्षा बूस्टर।
डेवूंग फार्मा का इस साल डिजिटल हेल्थकेयर में 300 अरब वोन का लक्ष्य, एकीकृत AI हेल्थकेयर प्लेटफॉर्म का अनावरण और राष्ट्रव्यापी दूरस्थ स्वास्थ्य निगरानी की योजना।
सत्यापित ईमेल और डायरेक्ट डायल अनलॉक करें
मुफ्त · क्रेडिट कार्ड की जरूरत नहीं
Daewoong Pharmaceutical के व्यवसाय, बाज़ारों और ग्रोथ सिग्नल के बारे में त्वरित उत्तर।

© 2026 Pubrio. सर्वाधिकार सुरक्षित।